Current treatment practice of herpes zoster.
The management of herpes zoster infection has been impacted by the development of oral and iv. antiviral therapies. There are clinical and historical features that help optimise the particular therapy course for a given patient. Additionally, there are common features of management in all patients with herpes zoster. In this review an understanding of the pathogenesis of herpes zoster is utilised as a starting point for the development of a rational approach to therapy. Clinical findings that impact decision making are emphasised and the appropriate goals for therapy are discussed.
Heald
P W
PW
Yale University School of Medicine, New Haven, Connecticut, USA. peter.heald@yale.edu
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D019433:Chickenpox Vaccine / Q000627:therapeutic use; D006562:Herpes Zoster / Q000188:drug therapy* / Q000276:immunology; D014645:Herpesvirus 3, Human / Q000472:pathogenicity; D006801:Humans
D000998:Antiviral Agents; D019433:Chickenpox Vaccine